The higher degree of mutations in the TP53 gene is associated with GBM cell lines with a higher resistance to cisplatin treatment and the cells with mutated and inactivated TP53 and a deregulated p53 pathway exhibit a higher degree of invasiveness, less apoptosis, and more proliferation than their wild-type TP53 counterparts [18]. Here, TP53 is linked to glioblastoma.